Novartis (NVS) Profit Margin (2006 - 2026)
Novartis (NVS) profit margin from Mar 31, 2006 to Mar 31, 2026. The current Novartis (NVS) profit margin is 23.34%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Novartis (NVS)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 25.64% | +11.07% |
| 2024 | 23.09% | -27.46% |
| 2023 | 31.83% | +98.88% |
| 2022 | 16.00% | -70.70% |
| 2021 | 54.63% | +237.67% |
| 2020 | 16.18% | -32.88% |
| 2019 | 24.10% | -11.90% |
| 2018 | 27.36% | +54.14% |
| 2017 | 17.75% | +30.71% |
| 2016 | 13.58% | -61.53% |
| 2015 | 35.29% | +85.40% |
| 2014 | 19.04% | +9.38% |
| 2013 | 17.40% | -2.42% |
| 2012 | 17.84% | +18.46% |
| 2011 | 15.06% | -20.73% |
| 2010 | 18.99% | +1.99% |
| 2009 | 18.62% | -3.22% |
| 2008 | 19.24% | -37.26% |
| 2007 | 30.67% | +50.07% |
| 2006 | 20.44% | N/A |
Comparison Novartis (NVS) profit margin with competitors
Novartis (NVS) profit margin is 23.34%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 37.36% | +60.09% |
| GILD | Gilead Sciences Inc | 29.04% | +24.44% |
| BMY | Bristol-Myers Squibb Company | 23.30% | -0.16% |
| GSK | GSK Plc | 22.77% | -2.43% |
| JNJ | Johnson & Johnson | 21.76% | -6.75% |
| AMGN | AMGEN Inc | 21.11% | -9.54% |
| AZN | Astrazeneca plc | 20.15% | -13.65% |
| PFE | Pfizer Inc | 18.59% | -20.34% |
| SNY | Sanofi | 14.35% | -38.51% |
| BIIB | Biogen Inc | 12.89% | -44.76% |
| OGN | Organon & Company | 10.00% | -57.15% |
| ABBV | Abbvie Inc | 4.63% | -80.16% |
| GRFS | Grifols SA | 4.29% | -81.62% |